Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

Many nanosized particulate systems are being developed as intravascular carriers to increase the levels of therapeutic agents delivered to targets, with the fewest side effects. The surface of these carriers is often functionalized with biological recognition molecules for specific, targeted delivery. However, there are a series of biological barriers in the body that prevent these carriers from localizing at their targets at sufficiently high therapeutic concentrations. Here we show a multistage delivery system that can carry, release over time and deliver two types of nanoparticles into primary endothelial cells. The multistage delivery system is based on biodegradable and biocompatible mesoporous silicon particles that have well-controlled shapes, sizes and pores. The use of this system is envisioned to open new avenues for avoiding biological barriers and delivering more than one therapeutic agent to the target at a time, in a time-controlled fashion.

[1]  V. Lehto,et al.  Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[2]  S. Kennel,et al.  Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[3]  A. Gabizon,et al.  Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. , 1991, Biochimica et biophysica acta.

[4]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[5]  William C Eckelman,et al.  Targeting proteins in vivo: in vitro guidelines. , 2006, Nuclear medicine and biology.

[6]  H. Dai,et al.  Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. C. Bayliss,et al.  The Culture of Mammalian Cells on Nanostructured Silicon , 1999 .

[8]  Robert Langer,et al.  Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.

[9]  Mauro Ferrari,et al.  Antibiological barrier nanovector technology for cancer applications , 2007, Expert opinion on drug delivery.

[10]  M. Ferrari.  Nanovector therapeutics. , 2005, Current opinion in chemical biology.

[11]  Michael J. Sailor,et al.  Compatibility of Primary Hepatocytes with Oxidized Nanoporous Silicon , 2001 .

[12]  P Bongrand,et al.  Diffusion of microspheres in shear flow near a wall: use to measure binding rates between attached molecules. , 2001, Biophysical journal.

[13]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[14]  Peter W. Swaan,et al.  Microfabricated Porous Silicon Particles Enhance Paracellular Delivery of Insulin Across Intestinal Caco-2 Cell Monolayers , 2004, Pharmaceutical Research.

[15]  Michael J. Sailor,et al.  Chemical Modification of Crystalline Porous Silicon Surfaces , 1999 .

[16]  M Ferrari,et al.  The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.

[17]  K. Kairemo,et al.  Targeted liposomal drug delivery in cancer. , 2004, Current pharmaceutical design.

[18]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Mauro Ferrari,et al.  Fantastic VoyagesNanodevices in Development Today Promise to Give Medicine Capabilities that Were Once Purely in the Realm of Fiction , 2006 .

[20]  Yuchun Wang,et al.  Surface modification of micromachined silicon filters , 2000 .

[21]  M. Ferrari,et al.  A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.

[22]  Michael J Sailor,et al.  Delivery of nanogram payloads using magnetic porous silicon microcarriers. , 2006, Lab on a chip.

[23]  L. Canham.  Bioactive silicon structure fabrication through nanoetching techniques , 1995 .

[24]  M. Teitell,et al.  The evolution of antibodies into versatile tumor-targeting agents. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  L. Canham,et al.  Derivatized Mesoporous Silicon with Dramatically Improved Stability in Simulated Human Blood Plasma , 1999 .

[26]  J. Buriak,et al.  Chemical and Biological Applications of Porous Silicon Technology , 2000 .

[27]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[28]  Vladimir P Torchilin,et al.  Multifunctional nanocarriers. , 2006, Advanced drug delivery reviews.

[29]  A. Alavi,et al.  Opportunities and Challenges , 1998, In Vitro Diagnostic Industry in China.

[30]  T. Mihaljevic,et al.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.

[31]  Shuming Nie,et al.  Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.

[32]  Mauro Ferrari,et al.  Adhesion of Microfabricated Particles on Vascular Endothelium: A Parametric Analysis , 2004, Annals of Biomedical Engineering.

[33]  Jennifer Sturgis,et al.  Bacteria-mediated delivery of nanoparticles and cargo into cells. , 2007, Nature nanotechnology.